An industrial polyaluminium chloride enquiry should identify the offered material, the meaning of its content statement and the water-treatment task being evaluated. A percentage on its own does not provide a complete basis for selecting a grade, comparing quotations or predicting a result in an actual water stream.
This guide uses PAC to mean polyaluminium chloride. Confirm that meaning in your enquiry because abbreviations can be ambiguous. It is a purchasing and evaluation guide, with no dosage, mixing procedure or universal treatment promise. The responsible technical team should define trials and handling under its own procedures and the supplied safety information.
First question: which product is being offered?
Record the product name, grade or model and actual supplied form. Retain any distinction between a powder, granule or liquid proposal. Ask which specification applies to the selected option, especially when a listing or conversation refers to several content ranges or available grades.
Match the quotation with the product identifier used on the TDS, SDS and proposed sample label. If those identifiers differ, request a mapping before the sample is evaluated. A broad PAC trade description is not enough to establish that the laboratory and purchasing team are discussing the same offered material.
Describe the intended use as precisely as possible. Industrial wastewater treatment and drinking-water treatment carry different qualification questions. A catalogue statement about water treatment does not establish approval for potable use or compliance with a particular buyer, jurisdiction or process requirement.
Second question: what does the content figure measure?
Ask for the named analyte or equivalent represented by the stated percentage, its test method and reporting basis. If a sheet reports content as Al2O3, retain that wording. Do not silently rename it product purity, aluminium metal content or another quantity. Each expression needs its own definition.
Record whether the value applies to the material as supplied or another stated basis. A comparison between different physical forms needs particular care. Do not rank a powder and a liquid solely by percentages whose definitions and basis have not been established.
Keep typical content and specification limits separate. Request clarification if a range could refer to several offered options rather than the acceptance limits of a single grade. Where a proposed-batch COA is available, ask how its results relate to the agreed specification and the material to be supplied.
Other grade data belong beside the content statement
Ask which additional parameters are relevant to the proposed grade and your application. These may include the product's stated basicity, insoluble matter, solution-related measurements and impurity information, depending on the material and specification. Request the definitions, methods and units instead of assuming that similarly named fields always have the same basis.
A parameter should be included because it supports a decision. Ask your technical team which incoming limits are mandatory and which information is needed to design an evaluation. Do not create an arbitrary quality score by adding unlike numbers from different sheets.
Colour can help describe the appearance of the supplied material, but it does not replace a chemical specification or an application trial. Likewise, a clear-looking photograph of water does not prove a treatment result for your stream. Keep visual descriptions separate from measured acceptance criteria.
Third question: what water stream is being treated?
The buyer should describe the source and variability of the water, the treatment objective and the process context. Share the data your responsible team considers relevant and identify any important gaps. The description should be specific to the actual stream rather than a generic label such as industrial water.
Record the target outcome in measurable terms. Clarify which incoming characteristics and operating conditions the team will monitor during assessment, and which downstream constraints matter. Where the stream changes over time, identify how representative samples will be selected and how that variability will be considered.
US EPA guidance discusses jar testing as a way to evaluate coagulation treatment conditions in the relevant water context. Its water-treatment assessment guidance is background reading, not an operating instruction for the product offered here. A qualified team must design the appropriate evaluation for the actual task.
A trial request is different from a dosage recommendation
A procurement enquiry can ask whether a proposed grade is available for evaluation and what supporting information can be supplied. It should not replace the treatment team's decisions about trial design, chemical handling, dosing or process control. Those decisions depend on the material, water and site conditions.
Before arranging a sample, agree what the trial must establish, which control or current treatment will be compared and which acceptance criteria will be used. Identify the sample and document set required. Keep the planning record separate from any later result so the criteria do not change silently after observations are known.
Do not interpret a favourable result in one water sample as a guarantee across all water conditions. Record the tested stream, material identifier and conditions. Your technical team should decide whether further assessment is needed for variability, scale or process changes.
Read the document set as three different kinds of information
Safety data sheet
Request the SDS for the identified product and have the responsible team review it for the intended site and use. Check the product identifier and revision. Safety information should accompany the actual supplied material; a document for another chemical or broadly similar trade name should not be accepted without resolving the mismatch.
Technical data sheet
Use the TDS to identify the grade and the meaning of the stated characteristics. Ask which figures are typical and which are specification limits. Keep the definitions of content, basicity and any other relevant measurement with the data so the comparison can be checked by another reviewer.
Certificate of analysis
Clarify whether a COA is representative, sample-related or linked to the proposed batch. Check product and lot identifiers and identify what each reported entry means. A representative example can support a discussion about document format, but it does not establish the results of a future shipment.
The SDS, TDS and COA guide provides a document-review checklist. Availability and scope should be confirmed for the specific enquiry. A guide explaining these document names is not evidence that every document or certification is available for every listing.
Structure a quotation comparison that can survive review
Use one table with separate sections for identity, technical scope, trial requirements and commercial scope. In each technical row, retain the analyte, unit, basis, method and document source. Mark missing information explicitly. Avoid a single percentage column labelled purity when the source actually reports a different defined quantity.
For the commercial rows, record the offered form, net quantity, package, destination, trade terms, timing and document requirements. Confirm any sample charges and transport arrangements. Price comparison is only meaningful within a defined scope, and a headline figure should not silently stand in for a delivered, qualified-material cost.
Where one offer differs, write the deviation in plain language and identify who must review it. If the proposed material or specification changes after the trial, revisit the relevant technical decision. An approval for one sample should not automatically attach to a differently identified offer.
A worked review sequence without invented test values
Imagine receiving two PAC offers for the same industrial wastewater enquiry. The first sheet states a content figure but omits its basis. The second gives a defined basis but uses a different supplied form. The initial task is clarification, not a ranking of the two numbers. Ask the missing questions and identify a common comparison method with the treatment team.
Next, give both offers the same stream description and trial objective. Request the sample identifiers and document information needed for assessment. Record whether the suppliers can answer the required identity and specification questions. That produces a technical shortlist based on evidence rather than a visual impression of the powder.
Finally, connect the selected sample record with the actual quotation and proposed order. List accepted limits, accepted deviations and open points. Confirm the batch documentation requirement and how the delivered package identifiers will be matched. This sequence preserves the difference between an enquiry, a trial and an accepted supply specification.
Questions to include in your PAC enquiry
If an answer is incomplete, retain the open point in the comparison and identify whether it prevents sampling, qualification or only the commercial decision. This avoids treating every missing item as equivalent and gives the next discussion a clear purpose. Keep clarification responses with the original sheet so the final accepted scope can be traced.
- Which exact product, grade and supplied form are proposed?
- What does the content percentage represent, and on which method and basis?
- Which additional parameters and impurity limits apply to that grade?
- Which SDS, TDS and batch-document information can be supplied?
- What sample scope and commercial arrangements can be discussed for the defined trial?
- Which qualifications, if any, are required for the intended use and supported by applicable evidence?
Browse the water-treatment coagulant listings, prepare the RFQ brief and contact Relia Chemical with the actual listing, stream context, quantity, package and destination. A precise question about the offered grade is a stronger starting point than an assumed universal PAC specification.